[{"address1": "Modi\u2019in Technology Park", "address2": "2 HaMa\u2019ayan Street", "city": "Hevel Modi'in", "zip": "7177871", "country": "Israel", "phone": "972 8 642 9100", "fax": "972 8 642 9101", "website": "https://www.biolinerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ella  Sorani Ph.D.", "age": 56, "title": "Chief Development Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 295000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Lacey", "title": "Head of Corporate Communications & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raziel  Fried", "title": "Treasurer & Budgetary Control Director", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.257, "open": 3.3699, "dayLow": 3.25, "dayHigh": 3.38, "regularMarketPreviousClose": 3.257, "regularMarketOpen": 3.3699, "regularMarketDayLow": 3.25, "regularMarketDayHigh": 3.38, "payoutRatio": 0.0, "beta": 0.59, "trailingPE": "Infinity", "forwardPE": -15.363637, "volume": 4791, "regularMarketVolume": 4791, "averageVolume": 35946, "averageVolume10days": 29760, "averageDailyVolume10Day": 29760, "bid": 3.3, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 15865700, "fiftyTwoWeekLow": 2.3, "fiftyTwoWeekHigh": 14.8, "allTimeHigh": 4122.0, "allTimeLow": 2.3, "priceToSalesTrailing12Months": 1.2458344, "fiftyDayAverage": 3.6208, "twoHundredDayAverage": 3.71985, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 8810718208, "profitMargins": -0.23377001, "floatShares": 2504110406, "sharesOutstanding": 4351357, "sharesShort": 180688, "sharesShortPriorMonth": 189496, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.041500002, "heldPercentInsiders": 0.03995, "heldPercentInstitutions": 0.00637, "shortRatio": 7.84, "shortPercentOfFloat": 0.0416, "impliedSharesOutstanding": 4693994, "bookValue": 0.007, "priceToBook": 482.85715, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -2977000, "trailingEps": 0.0, "forwardEps": -0.22, "lastSplitFactor": "1:40", "lastSplitDate": 1738195200, "enterpriseToRevenue": 691.851, "enterpriseToEbitda": -1052.529, "52WeekChange": -0.674, "SandP52WeekChange": 0.13287461, "quoteType": "EQUITY", "currentPrice": 3.38, "targetHighPrice": 26.0, "targetLowPrice": 12.0, "targetMeanPrice": 20.33333, "targetMedianPrice": 23.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 25212000, "totalCashPerShare": 0.01, "ebitda": -8371000, "totalDebt": 11378000, "quickRatio": 1.896, "currentRatio": 2.087, "totalRevenue": 12735000, "debtToEquity": 58.25, "revenuePerShare": 3.6, "returnOnAssets": -0.13603, "returnOnEquity": -0.21235001, "grossProfits": 6456000, "freeCashflow": -6817250, "operatingCashflow": -13484000, "revenueGrowth": -0.914, "grossMargins": 0.50695, "ebitdaMargins": -0.65732, "operatingMargins": -5.16862, "financialCurrency": "USD", "symbol": "BLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "BioLineRx Ltd.", "longName": "BioLineRx Ltd.", "exchange": "NCM", "messageBoardId": "finmb_5015080", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.776486, "regularMarketPrice": 3.38, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1311773400000, "postMarketChangePercent": -0.5917224, "postMarketPrice": 3.36, "postMarketChange": -0.02000022, "regularMarketChange": 0.123000145, "regularMarketDayRange": "3.25 - 3.38", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 35946, "fiftyTwoWeekLowChange": 1.0800002, "fiftyTwoWeekLowChangePercent": 0.4695653, "fiftyTwoWeekRange": "2.3 - 14.8", "fiftyTwoWeekHighChange": -11.42, "fiftyTwoWeekHighChangePercent": -0.77162164, "fiftyTwoWeekChangePercent": -67.4, "dividendDate": 1563148800, "earningsTimestamp": 1763991000, "earningsTimestampStart": 1763991000, "earningsTimestampEnd": 1763991000, "earningsCallTimestampStart": 1763991000, "earningsCallTimestampEnd": 1763991000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.0, "epsForward": -0.22, "epsCurrentYear": -0.68, "priceEpsCurrentYear": -4.970588, "fiftyDayAverageChange": -0.2407999, "fiftyDayAverageChangePercent": -0.06650461, "twoHundredDayAverageChange": -0.33984995, "twoHundredDayAverageChangePercent": -0.091361195, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1764969004, "regularMarketTime": 1764968400, "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]